Home
Conditions
Lupus Erythematosus, Systemic

Clinical trial condition

Lupus Erythematosus, Systemic

Explore clinical trials studying Lupus Erythematosus, Systemic. Study availability and eligibility vary by location and protocol.

840 public trials 218 recruiting studies

Refine in advanced search Browse all conditions

Lupus Erythematosus, Systemic trial results

Completed

Human Papilloma Virus Vaccination and Chronic Inflammatory Rheumatic Diseases.

NCT04180228

Conditions: Arthritis, Arthritis, Juvenile, Autoimmune Diseases, +10 more
Locations: Hôpital Femme Mère Enfant Bron, France

Hôpital Necke -, Enfants Malades Paris, France

Service de médecine interne, Centre hospitalier Lyon Sud Pierre-Bénite, France

View Trial Details

Completed

Clonal Hematopoiesis of Indeterminate Potential and Accelerated Atherosclerosis in Systemic Lupus Erythematosus

NCT05146414

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations: Hôpital Bichat Paris, France

View Trial Details

Completed

Laser Therapy for Patients With Systemic Lupus Erythematosus

NCT04453215

Conditions: Autoimmune Diseases, Chewing Function, Connective Tissue Diseases, +15 more
Locations: Istanbul university,Faculty of Dentistry Fatih, Turkey (Türkiye)

View Trial Details

Completed

Omega-3 Replacement With Krill Oil in Disease Management of SLE

NCT03626311

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Wallace Rheumatic Studies Center, LLC Beverly Hills, California, United States

UC Irvine Health Orange, California, United States

University of Miami Miami, Florida, United States

View all 19 locations

View Trial Details

Completed

Anti-ficolin-3 Antibodies in Lupus Nephritis

NCT03842787

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +12 more
Locations: JOUVE La Tronche, France

View Trial Details

Completed

Multicomponent Strategy to Implement a Clinical Practice Guideline and Improve Health Outcomes in People With SLE

NCT03537638

Conditions: Autoimmune Diseases, Behavior, Connective Tissue Diseases, +5 more
Locations: Servicio de Evaluación del Servicio Canario de la Salud Santa Cruz de Tenerife, Spain

View Trial Details

Completed

Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases

NCT03248518

Conditions: Ankylosis, Arthritis, Arthritis, Psoriatic, +33 more
Locations: NHS Grampian Aberdeen, United Kingdom

NHS Tayside Dundee, United Kingdom

NHS Lothian Edinburgh, United Kingdom

NHS Greater Glasgow and Clyde Glasgow, United Kingdom

View Trial Details

Completed

Role of PPAR-y Agonists in Immunomodulation and Vascular Prevention in SLE (PPAR-SLE)

NCT02338999

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +8 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Efficacy and Safety of Belimumab in Black Race Patients With Systemic Lupus Erythematosus (SLE)

NCT01632241

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations: GSK Investigational Site Birmingham, Alabama, United States

GSK Investigational Site Covina, California, United States

GSK Investigational Site La Palma, California, United States

GSK Investigational Site Lakewood, California, United States

View all 96 locations

View Trial Details

Completed

Phase Ib Study of SC Milatuzumab in SLE

NCT01845740

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Brain Diseases, +31 more
Locations: Cedars Sinai Medical Center-Wallace Rheumatic Study Center West Hollywood, California, United States

View Trial Details

Lupus Erythematosus, Systemic

Lupus Erythematosus, Systemic trial results

Related conditions